Delivery Order SPE2DR25D3201-SPE2DR26FT4PH
- Not listed
- The Defense Logistics Agency awarded a $1,309.59 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials on September 25, 2025, with completion expected by September 26, 2025. This competitive award utilizes a firm fixed price contract type with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and is a major pharmaceutical distributor providing critical medical supplies...
- The Defense Logistics Agency awarded a delivery order valued at $3,226.87 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,670.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL Solution in unit dose vials. The order, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is classified as a child contract under AmerisourceBergen's broader federal contracting relationship and involves no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,985.04 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials. This competitively awarded, firm fixed price delivery order was issued on May 23, 2025, with an ultimate completion date of May 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a delivery order valued at $12,881.25 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose vials on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a pediatric or specialized pharmaceutical supply requirement fulfilled through competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $1,910.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit-dose 3 mL vials. The order was competitively awarded without set-aside designation and is scheduled for completion by December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,528.21 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose vials. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion on August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a...
- The Defense Logistics Agency awarded a $1,973.31 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 1, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $13,916.52 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit-dose vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) calls for the pharmaceutical distributor to deliver the medication to its Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4PHDelivery Order
This delivery order, valued at $23,434.10 with a firm fixed price, was awarded on December 10, 2025, to AmerisourceBergen Drug Corp for the supply of Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. The contract is non-set-aside and competitively awarded, with performance to be completed by December 11, 2025, at the company's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency, which operates under the Department of Defense, is the funding federal agency for this pharmaceutical procurement. This delivery order represents a task issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Through this contract structure, the company provides critical pharmaceutical commodities to customers including the Defense Health Agency and U.S. Coast Guard, supporting military medical operations globally with specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.4k | 12/9/25 |